ESMO: Despite survival miss, Exelixis presses on with FDA prostate cancer bid as Ipsen scraps EU plan aliu Mon, 09/16/2024 – 16:14 More: ESMO: Despite survival miss, Exelixis presses on with FDA prostate cancer bid as Ipsen scraps EU plan
read morePhRMA pushes FDA to change ‘overly simplistic’ and ‘unduly restrictive’ online misinformation proposals ntaylor Mon, 09/16/2024 – 11:43 More: PhRMA pushes FDA to change ‘overly simplistic’ and ‘unduly restrictive’ online misinformation proposals Source: fierce
read moreSandoz, Liquidia score $137M win against United in years-long generic Remodulin dispute zbecker Mon, 09/16/2024 – 11:27 More: Sandoz, Liquidia score 7M win against United in years-long generic Remodulin dispute Source: fierce
read morePalisade Bio bolsters branding with bold new logo, website makeover apark Mon, 09/16/2024 – 11:13 More: Palisade Bio bolsters branding with bold new logo, website makeover Source: fierce
read moreLilly’s immunology unit scores another FDA nod with eczema treatment Ebglyss kdunleavy Mon, 09/16/2024 – 11:08 More: Lilly's immunology unit scores another FDA nod with eczema treatment Ebglyss Source: fierce
read more
The decision is expected to facilitate timely access to Bavarian Nordic’s Imvanex More: WHO adds first mpox vaccine to prequalification list Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals